These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 24298311)

  • 41. Modeling of hemophilia A using patient-specific induced pluripotent stem cells derived from urine cells.
    Jia B; Chen S; Zhao Z; Liu P; Cai J; Qin D; Du J; Wu C; Chen Q; Cai X; Zhang H; Yu Y; Pei D; Zhong M; Pan G
    Life Sci; 2014 Jul; 108(1):22-9. PubMed ID: 24834837
    [TBL] [Abstract][Full Text] [Related]  

  • 42. How to mend a broken heart: adult and induced pluripotent stem cell therapy for heart repair and regeneration.
    Wegener M; Bader A; Giri S
    Drug Discov Today; 2015 Jun; 20(6):667-85. PubMed ID: 25720353
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induced pluripotent stem cells in regenerative medicine and disease modeling.
    Walmsley GG; Hyun J; McArdle A; Senarath-Yapa K; Hu MS; Chung MT; Wong VW; Longaker MT; Wan DC
    Curr Stem Cell Res Ther; 2014 Mar; 9(2):73-81. PubMed ID: 24359141
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induced Pluripotent Stem Cells (iPSCs)-Roles in Regenerative Therapies, Disease Modelling and Drug Screening.
    Aboul-Soud MAM; Alzahrani AJ; Mahmoud A
    Cells; 2021 Sep; 10(9):. PubMed ID: 34571968
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induced pluripotent stem cells (iPSCs) derived from different cell sources and their potential for regenerative and personalized medicine.
    Shtrichman R; Germanguz I; Itskovitz-Eldor J
    Curr Mol Med; 2013 Jun; 13(5):792-805. PubMed ID: 23642060
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Disease-in-a-dish: the contribution of patient-specific induced pluripotent stem cell technology to regenerative rehabilitation.
    Mack DL; Guan X; Wagoner A; Walker SJ; Childers MK
    Am J Phys Med Rehabil; 2014 Nov; 93(11 Suppl 3):S155-68. PubMed ID: 25122102
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Generation of keratinocytes from normal and recessive dystrophic epidermolysis bullosa-induced pluripotent stem cells.
    Itoh M; Kiuru M; Cairo MS; Christiano AM
    Proc Natl Acad Sci U S A; 2011 May; 108(21):8797-802. PubMed ID: 21555586
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Use of Induced Pluripotent Stem Cells for the Study and Treatment of Liver Diseases.
    Hansel MC; Davila JC; Vosough M; Gramignoli R; Skvorak KJ; Dorko K; Marongiu F; Blake W; Strom SC
    Curr Protoc Toxicol; 2016 Feb; 67():14.13.1-14.13.27. PubMed ID: 26828329
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regenerative medicine for the heart: perspectives on stem-cell therapy.
    Cho GS; Fernandez L; Kwon C
    Antioxid Redox Signal; 2014 Nov; 21(14):2018-31. PubMed ID: 25133793
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induced pluripotent stem cell technology: a decade of progress.
    Shi Y; Inoue H; Wu JC; Yamanaka S
    Nat Rev Drug Discov; 2017 Feb; 16(2):115-130. PubMed ID: 27980341
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical Application of Induced Pluripotent Stem Cells in Cardiovascular Medicine.
    Chi HJ; Gao S; Yang XC; Cai J; Zhao WS; Sun H; Geng YJ
    Cardiology; 2015; 131(4):236-44. PubMed ID: 25969168
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regenerative Medicine/Cardiac Cell Therapy: Pluripotent Stem Cells.
    Duran AG; Reidell O; Stachelscheid H; Klose K; Gossen M; Falk V; Röll W; Stamm C
    Thorac Cardiovasc Surg; 2018 Jan; 66(1):53-62. PubMed ID: 29216651
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stem cells in pediatric cardiology.
    Patel P; Mital S
    Eur J Pediatr; 2013 Oct; 172(10):1287-92. PubMed ID: 23292032
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human induced pluripotent stem cells--from mechanisms to clinical applications.
    Drews K; Jozefczuk J; Prigione A; Adjaye J
    J Mol Med (Berl); 2012 Jul; 90(7):735-45. PubMed ID: 22643868
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Generating induced pluripotent stem cell derived endothelial cells and induced endothelial cells for cardiovascular disease modelling and therapeutic angiogenesis.
    Clayton ZE; Sadeghipour S; Patel S
    Int J Cardiol; 2015 Oct; 197():116-22. PubMed ID: 26123569
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aging in the mouse and perspectives of rejuvenation through induced pluripotent stem cells (iPSCs).
    Isobe K; Cheng Z; Ito S; Nishio N
    Results Probl Cell Differ; 2012; 55():413-27. PubMed ID: 22918818
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Current status of treating neurodegenerative disease with induced pluripotent stem cells.
    Pen AE; Jensen UB
    Acta Neurol Scand; 2017 Jan; 135(1):57-72. PubMed ID: 26748435
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Generation of porcine-induced pluripotent stem cells by using OCT4 and KLF4 porcine factors.
    Liu K; Ji G; Mao J; Liu M; Wang L; Chen C; Liu L
    Cell Reprogram; 2012 Dec; 14(6):505-13. PubMed ID: 23035653
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stem cell therapy: challenges ahead.
    Bhagavati S
    Indian J Pediatr; 2015 Mar; 82(3):286-91. PubMed ID: 24992980
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Introduction to a Compendium on Regenerative Cardiology.
    Bolli R; Hare J
    Circ Res; 2018 Jul; 123(2):129-131. PubMed ID: 29976682
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.